510(k) Report

510(k) · Cleared

Cleared

Syngo Brevis

K090038510(k) TraditionalCleared Apr 28, 2009112-day reviewClass II21 CFR 892.1000

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Medical Solutions USA, Inc. · LNH System, Nuclear Magnetic Resonance Imaging

Cleared on Apr 28, 2009 as substantially equivalent to K043216 (Confirma, Inc., 2005) and 1 other predicate after a 112-day review. Its family tree reaches back 6 generations to 1996.

Decided
Apr 28, 2009
Review
112 days
Class
Class II
Product code
LNH
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K954678 (1996). 31 ancestors in all, the oldest K913475 (1991). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2005: 1 other ancestor2004: 1 other ancestor2003: 4 other ancestors2002: 2 other ancestors2001: 3 other ancestors2000: 1 other ancestor1999: 1 other ancestor1998: 2 other ancestors1996: 3 other ancestors1995: 2 other ancestors1994: 3 other ancestors1991: 2 other ancestorsK954678 · Pro Vision · Algotec Systems, Ltd. · 1996K980648 · Pro Vision · Algotec Systems, Ltd. · 1998K992654 · Plug 'N View 3D, Version 1.0 · Voxar Limited · 1999K020546 · Fusion 7D · Mirada Solutions, Ltd. · 2002K031779 · Cadstream · Confirma, Inc. · 2003K041286 · Dynacad V1.0 · Mri Devices Corp. · 200419901995200020052010
Other ancestors, by generation 1 generation back: 1 other ancestor2 generations back: 12 other ancestors3 generations back: 8 other ancestors4 generations back: 3 other ancestors5 generations back: 1 other ancestor K041286 · Dynacad V1.0 · Mri Devices Corp. · 2004K031779 · Cadstream · Confirma, Inc. · 2003K020546 · Fusion 7D · Mirada Solutions, Ltd. · 2002K992654 · Plug 'N View 3D, Version 1.0 · Voxar Limited · 1999K980648 · Pro Vision · Algotec Systems, Ltd. · 1998K954678 · Pro Vision · Algotec Systems, Ltd. · 1996−50
  1. Root · 6 generations backK954678 Pro VisionAlgotec Systems, Ltd. · 1996
  2. 5 generations backK980648 Pro VisionAlgotec Systems, Ltd. · 1998
  3. 4 generations backK992654 Plug 'N View 3D, Version 1.0Voxar Limited · 1999
  4. 3 generations backK020546 Fusion 7DMirada Solutions, Ltd. · 2002
  5. 2 generations backK031779 CadstreamConfirma, Inc. · 2003
  6. 1 generation backK041286 Dynacad V1.0Mri Devices Corp. · 2004
  7. This deviceK090038 Syngo BrevisSiemens Medical Solutions USA, Inc. · 2009
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K954678Pro VisionAlgotec Systems, Ltd.1996—
−5K980648Pro VisionAlgotec Systems, Ltd.1998—
−4K992654Plug 'N View 3D, Version 1.0Voxar Limited1999—
−3K020546Fusion 7DMirada Solutions, Ltd.2002—
−2K031779CadstreamConfirma, Inc.2003—
−1K041286Dynacad V1.0Mri Devices Corp.2004—
0 (this device)K090038Syngo BrevisSiemens Medical Solutions USA, Inc.2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199120
199430
199520
199630
199820
199910
200010
200130
200220
200340
200410
200510
FIG. 1 — Lineage of K090038, 1996–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LNH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LNH device

  1. #1 K213693 MAGNETOM Vida with syngo MR XA50Ascore 23.0 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K043216Cadstream Version 4.0
Summary page 3
…the following cleared medical devices: Predicate Software FDA Clearance Number FDA Clearance Date Name CADstream V4.0 K043216 Jan 6, 2005 DynaCAD Vl.0 K041286 July 21, 2004 General Safety…
Confirma, Inc.2005—
*K041286Dynacad V1.0
Summary page 3
…earance Number FDA Clearance Date Name CADstream V4.0 K043216 Jan 6, 2005 DynaCAD Vl.0 K041286 July 21, 2004 General Safety and Effectiveness Concerns: The introduction of syngo BreVis has no significant…
Mri Devices Corp.2004—

Also cleared against K043216: 8 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 6 companies; a new generation was cleared every 2.5 years on median.
  • 7 of the 31 ancestors have a recall of any class.
  • 8 other devices also cite its predicate K043216.

How does its category compare?

All LNH devices

LNH System, Nuclear Magnetic Resonance Imaging: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.

FDA decisions per year · LNH

26in 2025

2007: 122008: 192009: 172010: 122011: 162012: 222013: 192014: 172015: 192016: 202017: 182018: 292019: 262020: 322021: 272022: 302023: 302024: 262025: 262026 (partial year): 24
2007high 32 (2020) · low 12 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LNH

122in 2025

2007: 35 days median2008: 53 days median2009: 70 days median2010: 94 days median2011: 81 days median2012: 89 days median2013: 108 days median2014: 108 days median2015: 140 days median2016: 108 days median2017: 98 days median2018: 128 days median2019: 62 days median2020: 121 days median2021: 87 days median2022: 74 days median2023: 124 days median2024: 104 days median2025: 122 days median2026 (partial year): 126 days median
2007high 140 (2015) · low 35 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LNH

8in 2025

2007: 252008: 122009: 72010: 172011: 112012: 52013: 22014: 132015: 12, 2 Class I2016: 12018: 712019: 52020: 42021: 412022: 132023: 10, 1 Class I2024: 42025: 8, 5 Class I2026 (partial year): 43
2007high 71 (2018) · low 0 (2017)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · LNH

1,263in 2025

2007: 1142008: 1672009: 1942010: 1652011: 1822012: 1702013: 1072014: 1192015: 1132016: 1352017: 1212018: 1582019: 1582020: 982021: 842022: 1382023: 1592024: 2812025: 1,263
2007high 1,263 (2025) · low 84 (2021)2025

MAUDE reports naming product code LNH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007123525114
2008195312167
200917707194
2010129417165
2011168111182
201222895170
2013191082107
20141710813119
20151914012 (2)113
2016201081135
201718980121
20182912871158
201926625158
202032121498
202127874184
2022307413138
20233012410 (1)159
2024261044281
2025261228 (5)1,263
20262412643—

What is it indicated for?

syngo BreVis is a software package intended for use in viewing and analyzing magnetic resonance imaging (MRI) studies. syngo BreVis supports evaluation of dynamic MR data. Depending on the region of interest, contrast agents may or may not be used. syngo BreVis automatically registers serial patient motion to minimize the impact of patient motion and visualizes different enhancement characteristics in those areas that are within the scope of the…

Read the full statement (322 words)

syngo BreVis is a software package intended for use in viewing and analyzing magnetic resonance imaging (MRI) studies. syngo BreVis supports evaluation of dynamic MR data. Depending on the region of interest, contrast agents may or may not be used.

syngo BreVis automatically registers serial patient motion to minimize the impact of patient motion and visualizes different enhancement characteristics in those areas that are within the scope of the indications for use of MRI FDA approved contrast agents (parametric image maps).

Furthermore, it performs other user-defined post-processing functions such as image subtractions, multiplanar reformats and maximum intensity projections.

The resulting information can be displayed in a variety of formats, including a parametric image overlaid onto the source image. syngo BreVis can also be used to provide measurements of the diameters, areas and volumes.

Furthermore syngo BreVis can evaluate the uptake characteristics of segmented tissues that are within the scope of the indications for use of MRI FDA approved contrast agents.

syngo BreVis includes software to support the use of interventional coils and MR stereotactic localization devices to perform MR-guided interventional procedures (syngo BreVis Biopsy). Using information from MR images regarding the coordinates of a user-specified region of interest and fiducial coordinates, syngo BreVis provides an automatic calculation of the location and depth of the targeted region of interest, such as a lesion or suspected lesion.

syngo BreVis is optimized for viewing breast MR studies, and it also displays images from a number of other imaging modalities, like digitized mammographic images. The images by other imaging modalities displayed with syngo BreVis must not be used for primary diagnostic interpretation.

syngo BreVis also includes the option to add annotations based on the American College of Radiology's BI-RADS (Breast Imaging and Data System).

When interpreted by a skilled physician, syngo BreVis provides information that may be useful in diagnosis. Patient management decisions should not be made based solely on the results of syngo BreVis analysis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K090038: Syngo Brevis.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K090038

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026